# Hans Gelderblom, M.D., Ph.D. – FDA Inspection, Mar 8, 2019

Source: https://www.keypedia.com/records/fda_inspections/hans-gelderblom-md-phd/a0d91330-730f-4523-999f-ad7145977922
Source feed: FDA_Inspections

> FDA inspection 1081851 of Hans Gelderblom, M.D., Ph.D., March 08, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081851
- Company Name: Hans Gelderblom, M.D., Ph.D.
- Inspection Date: 2019-03-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1254677 - 2024-10-17

## Related Officers

- [Investigator](https://www.keypedia.com/people/richard-w-berning/4637e321-8803-4fcf-911f-bbc810c3487d)

Company: https://www.keypedia.com/companies/hans-gelderblom-md-phd/594fc3e3-04bd-4940-babe-639f0b6dca8a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c